Latest Listings And Ipos News

Siren Gold Limited announces the early resignation of Managing Director Victor Rajasooriar, with Chairman Brian Rodan stepping in as Interim Managing Director while a permanent replacement is sought.

Redivium Limited has launched its Trading Division and secured key agreements as it pushes forward with European battery recycling projects, though funding challenges remain.

Kingsgate Consolidated Limited has announced an on-market share buy-back as part of its capital management strategy, signaling confidence amid current market conditions.

VDM Group Limited faces suspension on the ASX due to a joint venture dispute in Angola, halting exploration activities. The company is pivoting towards new critical minerals projects in Australia to restore trading and investor confidence.

BluGlass Limited has launched a $6 million Share Purchase Plan (SPP) offering new shares with attaching options to eligible shareholders, aiming to fund the scale-up of its visible laser production and support ongoing product development.

MCS Services Limited reported a solid cash position of $1.23 million at quarter-end and is actively exploring the sale of its Traffic Business subsidiary while awaiting key tender results.

VanEck Investments Limited has released a replacement Product Disclosure Statement for six Australian bond ETFs, reflecting updated reference indices and market conditions effective May 1, 2025.

Ark Mines Ltd has successfully raised A$1.5 million through a fully subscribed placement, enabling a faster development of its rare earth project in North Queensland.

Kore Potash Plc's shares have been suspended from trading on the ASX after the company missed its deadline to lodge a draft financing proposal for the Kola Project. The suspension follows a prior trading halt and will remain until regulatory compliance is restored.

Alice Queen Limited has voluntarily suspended trading of its shares on the ASX as it finalises a proposed capital raising, with an announcement expected by 5 May 2025.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.